1Xhaard A, Robin M, Scieux C et aL Increased incidence ofcytomegalovirus retinitis after allogeneic hematopoietic stem ceiltransplantation. Transplantation, 2007, 33 8 80-83.
2Crippa F, Corey L,+ Chuang EL et at. Virological* clinical andophthalmologic features of cytomegalovirus retinitis afterhematopoietic stem cell transplantation. Clin Infect Dis, 20.01,32,214-219.
3Aw MM, Murugasu B, Tan AW, et al. Quantitation ofperipheral blood cytomegalovirus DNA for monitoring recurrentcytomegalovirus retinitis in pediatric solid orgati tfarmplantrecipients. Pediatr Transplant, 200.0, 4:100-106.
5Huynh N, Daniels AB Kohanim S.,et al. Medical treatment forcytomegalovirus retinitis. Int Ophthalmol Clin,2011,51:93-103.
6Larsson K,Lonnqvist B, Ringden O, et al. CMV retinitis afterallogeneic bone marrow transplantation : a report of five cases.Transpl Infect Dis, 20024 : 75-79.
4Jabs DA.AIDS and ophthalmology 2008.Arch Ophthalmol,2008,126:1143-1146.
5Jabs DA,Martin BK,Ricks MO,et al.Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression.Arch Ophthalmol,1996,114:821-827.
6Lee SS,Hughes PM,Robinson MR.Recent advances in drug delivery systems for treating ocular complications of systemic diseases.Curr Opin Ophthalmol,2009,20:511-519.
7Venkatesh KK,Biswas J,Kumarasamy N.Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus / acquired immune deficiency syndrome.Indian J Ophthalmol,2008,56:391-393.
8Burd EM,Pulido JS,Puro DG,et al.Maintenance of rep1icative intermediates in ganciclovir-treated human cytomegalovirusinfected retinal glia.Arch Ophthalmol,1996,114:856-861.
9Biron KK.Antiviral drugs for cytomegalovirus diseases.Antiviral Res,2006,71:154-163.
10Jabs DA,Enger C,Bartlett JG.Cytomegalovirus retinitis and acquired immunodeficiency syndrome.Arch Ophthalmol,1989,107:75-80.
